These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6746709)

  • 21. Synthesis and antineoplastic activity of CNC-cysteamine and related compounds.
    Tang WC; Schmid J; Fiebig HH; Eisenbrand G
    J Cancer Res Clin Oncol; 1986; 111(1):25-30. PubMed ID: 3949847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticancer agents: N'-(2-chloroethyl)-N'-nitrosocarbamoyl amino acid derivatives of steroid hormones.
    Eisenbrand G; Berger M; Fischer J; Schneider M; Zeller W; Tang W
    Cancer Treat Rev; 1987 Dec; 14(3-4):285-90. PubMed ID: 3440250
    [No Abstract]   [Full Text] [Related]  

  • 23. Antitumor action of N-(2-chloroethyl)-N-nitrosocarbamoyl derivatives of biologically active polypeptide hormone fragments.
    Jeney A; Kopper L; Nagy P; Lapis K; Süli-Vargha H; Medzihradszky K
    Cancer Chemother Pharmacol; 1986; 16(2):129-32. PubMed ID: 3948298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
    Fujimoto S; Tashiro T; Ogawa M
    Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats.
    Habs M; Reinbold H; Eisenbrand G; Bhide S; Goga-Ionescu S; Schmähl D
    J Cancer Res Clin Oncol; 1981; 101(3):285-302. PubMed ID: 7309781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new comprehensive technique of catheterisation, blood sampling, sample preparation and sample analysis by means of high-pressure liquid chromatography for pharmacokinetic studies with estradiol-linked nitrosoureas and their metabolites.
    Betsch B; Berger MR; Spiegelhalder B
    Arzneimittelforschung; 1990 Sep; 40(9):1022-5. PubMed ID: 2080936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental and clinical studies of the antitumor activity of 1-methyl-1-nitrosourea (NSC-23909).
    Emanuel NM; Vermel EM; Ostrovskaya LA; Korman NP
    Cancer Chemother Rep; 1974; 58(2):135-48. PubMed ID: 4830495
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthesis and antitumor activity of N-terminal proline-containing peptide-(chloroethyl)nitrosoureas.
    Süli-Vargha H; Jeney A; Lapis K; Medzihradszky K
    J Med Chem; 1987 Mar; 30(3):583-6. PubMed ID: 3820230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and activities of antitumor agents.
    Suami T; Machinami T; Hisamatsu T
    J Med Chem; 1979 Mar; 22(3):247-50. PubMed ID: 423206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticancer efficacy of 2-chloroethylnitrosocarbamoyl derivatives of L-alanine, glycine, their di- and tripeptide homologues and the respective amides in methylnitrosourea-induced rat mammary carcinoma.
    Klenner T; Berger MR; Eisenbrand G; Schmähl D
    Br J Cancer; 1989 Mar; 59(3):335-40. PubMed ID: 2930696
    [No Abstract]   [Full Text] [Related]  

  • 31. Quantitative structure-activity relationships in anticancer agents. Activity of selected nitrosoureas against a solid tumor, the Lewis lung carcinoma.
    Montgomery JA; Mayo JG
    J Med Chem; 1974 May; 17(5):477-80. PubMed ID: 4830248
    [No Abstract]   [Full Text] [Related]  

  • 32. Nitrosoureas: a review of experimental antitumor activity.
    Schabel FM
    Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L1210 leukemia i.v. implanted as a model for testing short-chain nitrosourea analogs.
    Schmid JR; Fiebig HH; Eisenbrand G; Löhr GW
    J Cancer Res Clin Oncol; 1986; 111(1):31-4. PubMed ID: 3949848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Letter: Antitumor activities of 3-(methyl-alpha-D-glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea.
    Iwasaki M; Okawa H; Ninomiya K; Sekine J; Nagamatsu Y
    Gan; 1975 Jun; 66(3):347-8. PubMed ID: 1181236
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytostatic action of two nitrosoureas derived from cysteamine.
    Bourut C; Chenu E; Godenèche D; Madelmont JC; Maral R; Mathé G; Meyniel G
    Br J Pharmacol; 1986 Nov; 89(3):539-46. PubMed ID: 3801787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of the mechanism of action of the tumour-inhibitory nitrosoureas.
    Connors TA; Hare JR
    Biochem Pharmacol; 1975 Dec; 24(23):2133-40. PubMed ID: 1212261
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bifunctional derivatives of N-nitroso-alkylurea].
    Emanuel' NM; Konovalova NP; D'iachkovskaia RF; Rozenberg AN
    Vopr Onkol; 1976; 22(10):72-7. PubMed ID: 1014497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride on experimental brain tumors.
    Hasegawa H; Shapiro WR; Posner JB; Basler G
    Cancer Res; 1979 Jul; 39(7 Pt 1):2687-90. PubMed ID: 445472
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea on experimental tumors.
    Hisamatsu T; Uchida S
    Gan; 1977 Dec; 68(6):819-24. PubMed ID: 202535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status of nitrosoureas under development in Japan.
    Ogawa M; Fujimoto S
    Recent Results Cancer Res; 1981; 76():115-24. PubMed ID: 6453413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.